Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

A kind of external use triptolide lipid nanoparticle and preparation method

A nanotechnology of triptolide and solid lipid, which is applied in the field of medicine, can solve the problems of organic solvent residue and high equipment requirements, and achieve the effect of high encapsulation efficiency

Active Publication Date: 2020-07-31
FUDAN UNIV SHANGHAI CANCER CENT
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The preparation method described is a rapid membrane emulsification method. This patent requires high equipment and is carried out under nitrogen conditions, and there is a possibility of residual organic solvents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of external use triptolide lipid nanoparticle and preparation method
  • A kind of external use triptolide lipid nanoparticle and preparation method
  • A kind of external use triptolide lipid nanoparticle and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] Mix triptolide 7.5mg, stearic acid 75mg, TPGS 150mg, Transcutol HP 75mg at 80°C, -1 Stir for 10 minutes under the same conditions to form the oil phase;

[0093] Heat 20ml of deionized water to the same temperature as the oil phase, and add it dropwise to the oil phase to make the system appear uniform and transparent, and continue to stir for 10 minutes to obtain triptolide solid lipid nanoparticle colostrum;

[0094] Rapidly disperse the above colostrum into 20 times the volume of colostrum in ice water at a temperature of 0±2° C., stir and solidify for 10 minutes to obtain triptolide solid lipid nanoparticles.

Embodiment 2

[0096] Mix triptolide 7.5mg, glyceryl behenate 80mg, TPGS 150mg, Transcutol HP75mg at 80°C, -1 Stir for 10 minutes under the same conditions to form the oil phase;

[0097] Heat 25ml of deionized water to the same temperature as the oil phase, and add it dropwise to the oil phase to make the system appear uniform and transparent, and continue to stir for 10 minutes to obtain triptolide solid lipid nanoparticle colostrum;

[0098] The above-mentioned colostrum is rapidly dispersed into 15 times the volume of the colostrum in ice water at a temperature of 0±2° C., stirred and solidified for 10 minutes to obtain triptolide solid lipid nanoparticles.

Embodiment 3

[0100] Mix triptolide 6.3mg, glyceryl behenate 75mg, Tween 80 150mg, Transcutol HP 75mg at 90°C, -1 Stir for 10 minutes under the same conditions to form the oil phase;

[0101] Heat 15ml of deionized water to the same temperature as the oil phase, and add it dropwise to the oil phase to make the system appear uniform and transparent, and continue stirring for 10 minutes to obtain triptolide solid lipid nanoparticle colostrum;

[0102] Rapidly disperse the above colostrum into 20 times the volume of colostrum in ice water at a temperature of 0±2° C., stir and solidify for 10 minutes to obtain triptolide solid lipid nanoparticles.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of medicines, and in particular to triptolide lipid nanoparticles for external use as well as a preparation method and an application of the triptolide lipid nanoparticles, wherein the triptolide lipid nanoparticles include triptolide solid lipid nanoparticles and a triptolide nano-structural lipid carrier. The triptolide lipid nanoparticles mainly consist of thefollowing ingredients: triptolide which serves as a medicinal raw material, the lipid carrier, a surfactant, a cosurfactant and water. The nanoparticles prepared by the invention are relatively highin encapsulation efficiency and cumulated transdermal permeation amount in vitro; based upon in-vitro pharmacokinetic researches, it is indicated that the triptolide lipid nanoparticles are excellentin sustained release effect, and a 'peak-valley phenomenon' can be effectively avoided. Based upon in-vivo pharmacodynamic experiments, it is indicated that the triptolide lipid nanoparticles, while effectively developing a therapeutic effect, can greatly reduce toxic and side effects. A preparing process of the lipid nanoparticles is free from residue of organic solvents; the technological process is easy to control and capable of achieving large-scale production; and the method has a good application prospect in the field of transdermal drug delivery.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to triptolide lipid nanoparticles for external use and a preparation method thereof. Background technique [0002] Triptolide (TPL), also known as triptolide, is one of the main active ingredients of the traditional Chinese medicine Triptolide, and its molecular formula is C 20 h 24 o 6 , the structural formula is as follows: [0003] [0004] Triptolide has anti-inflammatory, analgesic, anti-tumor and immunomodulatory effects, and is often used in the treatment of rheumatoid arthritis, skin eczema, immunosuppression, nephrotic syndrome and malignant tumors, and has good effects. [0005] However, triptolide has a short half-life and high toxicity. After oral administration, the absorption and elimination rate is fast, and it is easy to cause adverse reactions in the digestive system and genitourinary system. 50 It is 0.8mg / Kg. Therefore, changing its administration route a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/52A61K31/585A61P17/00
CPCA61K9/0014A61K9/5031A61K31/585A61P17/00
Inventor 刘继勇顾永卫顾清杨盟唐晓萌王婷
Owner FUDAN UNIV SHANGHAI CANCER CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com